SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-17-002735
Filing Date
2017-10-24
Accepted
2017-10-24 17:23:13
Documents
1
Period of Report
2017-10-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT walsh_f3.html 3  
1 OWNERSHIP DOCUMENT walsh_f3.xml 3 1495
  Complete submission text file 0001683168-17-002735.txt   3001
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Issuer) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address 14282 FRANKLIN AVE. TUSTIN CA 92780
Business Address
Walsh Patrick D (Reporting) CIK: 0001720568 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32839 | Film No.: 171151617